Comparing the effects of decreasing prescription opioid shipments and the release of an abuse deterrent OxyContin formulation on opioid overdose fatalities in WV: an interrupted time series study
The 2010 release of an abuse deterrent formulation (ADF) of OxyContin, a brand name prescription opioid, has been cited as a major driver for the reduction in prescription drug misuse and the associated increa...
Source: Substance Abuse Treatment, Prevention, and Policy - Category: Addiction Authors: Eric W. Lundstrom, Zheng Dai, Caroline P. Groth, Brian Hendricks, Erin L. Winstanley, Marie Abate and Gordon S. Smith Tags: Research Source Type: research
More News: Addiction | Overdose | Oxycodone | OxyContin | Study | Substance Abuse | Substance Abuse Disorders